delphinidin has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Currie, DM; Diaz, CA; Kamani, N; Ludvigsdottir, GK | 1 |
| Bertolli, V; Cattoretti, G; Delia, D; Deliliers, GL; Orazi, A; Oriani, A; Quirici, N; Soligo, D | 1 |
1 review(s) available for delphinidin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Topical treatment of sclerodermoid chronic graft vs. host disease.
Topics: Administration, Topical; Adolescent; Bone Marrow Transplantation; Chronic Disease; Contracture; Exercise Therapy; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Myelodysplastic Syndromes; Paraffin; Range of Motion, Articular; Scleroderma, Localized; Transplantation, Homologous; Treatment Outcome | 2002 |
1 other study(ies) available for delphinidin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
Topics: Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antigens, CD; Antigens, CD34; Biopsy; Bone Marrow; Bone Marrow Cells; Fixatives; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Paraffin; Primary Myelofibrosis | 1991 |